Where I see patients (1)
My reviews
Selected research
-
IL-6 underlies microenvironment immunosuppression and resistance to therapy in glioblastoma.
bioRxiv : the preprint server for biology
-
Correction: Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways.
Cancer discovery
-
Longitudinal profiling of IDH-mutant astrocytomas reveals acquired RAS-MAPK pathway mutations associated with inferior survival.
Neuro-oncology advances
Clinical trials
Contact me
- Request appointment
- Refer a patient
- (415) 353-7500
4.9